로딩 중…
지수 로딩 중…
Aktis Oncology, Inc.
AKTS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$22.23+0.72%
2026-08-03
Financials
Valuation Metrics
Aktis Oncology, Inc.'s Market Cap is $1.23B. Ranked #2380 of 3,112 in US market (top 76%), #957 of 1,445 on NASDAQ (top 66%), #178 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 66%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.23B | US#2,380/3,112 Sec#178/269 |
| Revenue | $6M | US#2,933/3,112 Sec#186/269 |
| Net Income | $-64M | US—/3,112 Sec—/269 |
| Total Assets | $265M | US#2,930/3,112 Sec#228/269 |
| Net Assets | $-146M | US#3,016/3,112 Sec#267/269 |
| Value | ||
| P/S | 189.14x | US#2,924/3,112 Sec#188/269 |
| FCF Yield | -6.00% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -24.06% | US#2,819/3,112 Sec#141/269 |
| Op. Margin | -1149.52% | US#2,926/3,112 Sec#180/269 |
| Revenue Growth | 336.92% | US#45/3,112 Sec#15/269 |
| Financial Health | ||
| Total Debt | $12M | US#2,768/3,112 Sec#195/269 |
| FCF | $-74M | US#2,528/3,112 Sec#130/269 |
| Cash | $38M | US#2,690/3,112 Sec#241/269 |
| Current Ratio | 7.37x | US#321/3,112 Sec#106/269 |
| Performance | ||
| 1M Return | -30.01% | US#3,065/3,112 Sec#256/269 |
| From 52W High | -34.98% | US#2,360/3,112 Sec#179/269 |
| 1Y MDD | -32.19% | US#1,524/3,112 Sec#97/269 |
| Trading | ||
| Volume | 314,404 shares | US#2,386/3,112 Sec#231/269 |
| Trading Value | $7M | US#2,527/3,112 Sec#204/269 |